Scribe Therapeutics Inc. · NASDAQ:SCTX
Scribe Therapeutics Inc. shareholders
As of Sep 30, 2026, 60 institutions reported holding Scribe Therapeutics Inc., 85.5% of its shares. Largest: a16z Capital Management, L.L.C., Avoro Capital Advisors LLC and Ra Capital Management, L.P. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Scribe Therapeutics Inc. | Change | Filed |
|---|---|---|---|---|
| a16z Capital Management, L.L.C. | 3.08M | 16.3% | new | Nov 16, 2026 |
| Avoro Capital Advisors LLC | 2.6M | 13.7% | new | Nov 16, 2026 |
| Ra Capital Management, L.P. | 1.8M | 9.5% | new | Nov 16, 2026 |
| Orbimed Advisors LLC | 1.35M | 7.1% | new | Nov 16, 2026 |
| Perceptive Advisors LLC | 920K | 4.9% | new | Nov 16, 2026 |
| ARK | 787K | 4.2% | new | Nov 13, 2026 |
| Baker Bros. Advisors LP | 689K | 3.6% | new | Nov 16, 2026 |
| T. Rowe Price | 685K | 3.6% | new | Nov 16, 2026 |
| BlackRock | 680K | 3.6% | new | Nov 13, 2026 |
| Vanguard | 543K | 2.9% | new | Nov 13, 2026 |